Vesicular Drug Delivery Systems Liposomes
Vesicular Drug Delivery Systems
Liposomes
Liposomes are concentric
bilayered vesicles in which an
aqueous volume is entirely
enclosed by a membranous lipid
bilayer mainly composed of
natural or synthetic
phospholipids.
OR
Liposomes (lipid vesicles) are
sealed sacs in the micron or
submicron range dispersed in an
aqueous environment.
Hydrophilic
Hydrophobic
Spherical vesicles with a phospholipid bilayer (Bangham et al. 1965)
What is a Liposome?
How they are formed?
Liposomes are formed by the self-assembly of phospholipid
molecules in an aqueous environment.
ADVANTAGES
Provides selective passive targeting to tumour tissues ( liposomal doxorubicin) Enhanced SolubilityImproved pharmacokinetic effectsReduction in toxicity of the encapsulated agentSuitable for delivery of hydrophobic, Amphipathic and Hydrophilic
drugs
Close resemblance with the natural membrane structure
Biocompatible, Biodegradable, Non toxic, Non-immunogenic
Can serve as a device for controlled release
Methods to overcome these limitations
Incorporation of lipids like cholesterol
Steric stabilization by high mol. wt surfactants like poloxamer.
Freeze drying
Polymerization of the vesicle in its own form.
PROBLEMS
- Physicochemical instability
- Prone to degradation by oxidation and hydrolysis
Cross-Section of a Liposome
H2O Layer Lipid Layer
Polar Lipids (Phospholipid)
LipidSoluble ingredients(Drugs, Nutrients &
vitamins)
WaterSoluble ingredients(Drugs, Nutrients &
vitamins)
Basic Components of Liposomal System
Vesicle Former
Structural Lipid
Charge Inducer
Polar Head Groups
Three carbon glycerol
PHOSPHOLIPIDS
Natural Source – Eggs for PC, PE, Sphingomyelin Soy bean for PC, PE, PIModified natural Phospholipids – Hydrogenation to reduce degree of unsaturationSynthetic Phospholipids
The parts of a phospholipid molecule. Phosphatidylcholine, represented schematically (A), in formula (B), as a space-filling model
(C), and as a symbol (D). The kink due to the cis-double bond is exaggerated in these drawings for emphasis.
Structural Lipid – Cholesterol, Tocopherol
Improves the fluidity of the bilayer
Minimizes leaching out of water soluble drug
Improves stability in biological fluids – reduce interaction
with plasma proteins
CHARGE INDUCERS – Dicetyl Phosphate, Sod. Cholate, Stearylamine
Prevents aggregation
Increases drug loading
The structure of cholesterol. Cholesterol is represented by a formula in (A), by a schematic drawing in (B),
and as a space-filling model in (C).
Classification of Liposomes
Liposome classification based on composition and mode of drug delivery
SmallUnilamellarVesicle(SUV)
LargeUnilamellarVesicle(LUV)
MultilamellarVesicle(MLV)
Typical Size Ranges: SLV: 20-50 nm – MLV:100-1000 nm
Formation of a Liposome
Mechanical methods
Hand shaking methods (MLV)
Extrusion through Polycarbonate filters (OLV)
Microfluidizer technique (mainly SUV)
High Pressure homogenization (mainly SUV)
Replacement of Organic Solvent by Aqueous medium
Removal of organic solvent (MLV, OLV, SUV)
Use of water immiscible solvents (MLV,OLV,SUV)
Reverse Phase Evaporation (LUV, OLV, MLV)
Detergent Removal Technique
Gel extrusion chromatography (SUV)
Slow dialysis (LUV, OLV, MLV)
PREPARATION OF LIPOSOMES
Hand Shaken/Film Hydration Technique (MLV) (Bangam et al, 1965)
Dehydration / Rehydration Vesicles (DRV)
• Efficient for direct loading of drugs
• Avoids use of Sonication, Organic solvents, Detergents
Solvent Evaporation
Processes for
Liposome Preparation
The lipid is initially dissolved by an aqueous solution of the detergent to form mixed lipid-detergent micelles, and the detergent is then removed by a diffusion-based process such as dialysis, diafiltration, or gel chromatography.
Uni- or oligolamellar vesicles ranging in diameter from SUV size up to several micrometers depending on the conditions used.
Ionic detergents, such as cholate and deoxycholate or nonionic detergents such as Triton X 100 and octylglucoside, have been used.
Detergent removal methods have been especially useful for functional reconstitution of membrane proteins.
Disadvantages
Encapsulation efficiency is low compared with most other methods.
Detergent removal by ordinary dialysis techniques is a tedious process.
Even traces of detergent can have pronounced effects on liposome
permeability and can greatly increase the transmembrane movement of PL.
Detergents may also have deleterious effects on the material being
encapsulated.
Detergent Removal Technique
Mean Size & Size distribution - Electron Microscopy
Dynamic Light Scattering (PCS)
Surface Potential & Surface pH - Microelectrophoresis
No of lamellae - Small angle X ray Scattering, NMR, Electron microscopy
Structural & Motional behavior
of lipids - DSC, ESR, NMR
Surface Chemical Analysis - XPS, SIMS, NMR
CHARACTERIZATION OF LIPOSOMES
Quality Control Assays of Liposome Formulation
Centrifree
- Suitable dilution is necessary
- Higher concentration of lipid blocks membrane
Adv : Rapid, requires small sample volume
Disadv : Expensive, Lipid concentration cannot exceed 5mg/mL
Gel Chromtography
- Sepharose/Sephadex
- Liposomes larger size pass through void volume
Adv : Sample recovery
Disadv : Slow and tedious, dilution of samples
REMOVAL OF UNENCAPSULATED DRUG
Dialysis
- Controlled and minimized by avoiding large dilution steps
- Several steps of small dil. vol (5-10 fold original dispersion)
Adv : Sample recovery
Disadv : Inaccurate and impossible to determine critical point
Protamine Aggregation
Adv : Economical
Disadv : Slow with neutral/positive charged liposomes
Contamination of the sample
Ultracentrifugation
- Subjected to high forces, can modify physically
Advantages and disadvantages of the different methods of separation of the entrapped from the unentrapped drug
I.V Injection
Uptake RES (Release in cell)
Disintegration in blood
Long circulation (Slow release in blood and accumulation at target site (non-MPS)
IN VIVO FATE OF LIPOSOME
Rate and Extent of MPS uptake depend on- Size- Rigidity- Hydrophilicity- Charge of the liposomes
IN VIVO BEHAVIOR OF LIPOSOMES
a. Conventional liposomes are opsonized by plasma proteins and trapped by RES. Fluid liposomes are also attacked by lipoproteins.b. Opsonins ans lipoproteins hardly attack the rigid liposomes.c. PEG coating protects liposomes against opsonization and attack of lipoproteins by
surface water layer.d. Unknown mechanisms that protect liposomes being recognized as foreign. One
possibility is that some molecules which are recognized as self are bound on the surface of liposomes and protect them.
Predominant mechanisms of intracellular drug delivery by liposomes. 1 - coated pit endocytosis of conventional, pH-sensitive and cationic liposomes; 2 - release of drug in the acidic endosome by pH-sensitive liposomes; 3 - intravascular and/or extracellular drug release from long circulating liposomes; 4 - receptor mediated endocytosis of immunoliposomes; 5 - fusion of cationic liposomes with plasma membrane.
TAILORING OF LIPOSOMES
Long Circulating Liposomes (Stealth/Sterically Stabilized)
- PEG-PE, Monosialoganglioside, Phosphoinositol
Targeted Liposomes
- Passive targeting (Conventional Liposomes)- Active targeting (Ligand Strategies: Folic acid,
Apolipoprotein E, Transferrin)
Polymerized Liposomes- Stability, artificial blood substitutes
pH & Temperature Sensitive Liposomes- Leaky in low pH (Surrounding cancerous tissue)- PL with Tc higher than body temp. (applying heat externally)
Cationic liposomes- Gene transfection (Lipoplex)
Immunoliposomes
Modified liposomes (stealth liposomes)
Hydrophilic polyoxyethylene lipids incorporated into liposome
Increased half-life is be due to a reduced coating (opsonisation) of these liposomes by plasma proteins
Coating with hydrophilic, polyethylene glycol (PEG) chains reduces the deposition of plasma proteins (by retaining water of hydration) and makes the liposomes more biocompatible (“stealthy”).
The hydrophilic barrier also retards disintegration of the liposomes
through exchange and/or transfer of liposomal phospholipids to high
density lipoproteins. PEG = polyethylene glycol.
Hydrophilic polymer coating
attracts water to the liposomes
surface, presenting a barrier to the
adherence of protein opsonins.
A decrease in opsonisation of the
liposomes in turn leads to a
decreased rate and extent of
liposome uptake into the
mononuclear phagocyte system,
resulting in increased circulation
half-lives.
LONG-CIRCULATING LIPOSOMES
Cationic liposomes
positively charged lipid dropletscan interact with negatively charged DNA
to wrap it up and deliver to cells
Positively charged lipid heads
Lipofectin, lipofectamine, lipofectase….
Inside liposomes DNA is resistant to degradation
Immunoliposomes for active targeting
Antibodies to intracellular myosin target liposomes
to infarcted areas of heart
Antibody against tumor specific molecules will target them to tumors
DNA delivery of Genes by Liposomes
Cheaper than viruses
No immune response
Especially good for in-lung delivery (cystic fibrosis)
100-1000 times more plasmid DNA needed for the same transfer efficiency as for viral vector
Lipofection
APPLICATIONSCancer
Antimicrobial agents – Leishmaniasis (Amphotericin B)
Gene therapy
Immunological Adjuvants
Liposome entrapped DNA delivery
Transdermal drug delivery
Vaccine adjuvants
Enzyme replacement
Cosmetics
Topical applications
Pulmonary delivery
Leishmaniasis
Lysosomal storage diseases
Ophthalmic delivery of drugs
Pharmacological Basis for Liposome Delivery of Anti-Cancer Agents
• Slow Release: reduced peak levels of free drug and
prolonged tumor exposure
• Change in Biodistribution: avoiding drug
deposition in certain tissues will reduce tissue-
specific toxicities
• Tumor Targeting: passive accumulation by
enhanced permeability and retention (EPR) effect
Parameters Affecting Delivery of Liposomal Drugs to Tumors
Tumor Factors
• Blood Flow Rate
• Vascular
Permeability
• Interstitial Pressure
• Phagocytic Activity
Liposome Factors
• Long circulation time
• Stability (drug
retention)
• Small vesicle size
• RES Function
List of Liposome products
Thank You